ResMed Inc.
RMD
$245.73
-$13.29-5.13%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.99% | 29.21% | 37.20% | 37.03% | 40.24% |
| Total Depreciation and Amortization | 14.63% | 13.08% | 11.43% | 0.75% | 3.05% |
| Total Amortization of Deferred Charges | -3.74% | -5.59% | -7.21% | -6.45% | -5.32% |
| Total Other Non-Cash Items | 27.64% | -10.22% | -17.60% | 9.52% | -18.63% |
| Change in Net Operating Assets | 196.91% | 2,116.57% | -62.63% | 120.05% | 41.47% |
| Cash from Operations | 29.68% | 30.74% | 25.00% | 37.91% | 36.81% |
| Capital Expenditure | -45.33% | -31.77% | 9.65% | 22.81% | 27.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -493.28% | -361.58% | -4.33% | 82.33% | 79.11% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.36% | 99.19% | 178.86% | 81.72% | 82.71% |
| Cash from Investing | -135.55% | -114.71% | 25.85% | 58.18% | 56.86% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | 98.20% | 98.53% | 95.21% | 50.74% | 17.78% |
| Issuance of Common Stock | 13.40% | 22.76% | 40.20% | 47.22% | 50.83% |
| Repurchase of Common Stock | -114.96% | -100.27% | -100.36% | -146.54% | -311.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.46% | -10.75% | -10.12% | -9.90% | -9.61% |
| Other Financing Activities | -1,169.59% | -1,169.59% | -805.65% | 74.39% | 76.60% |
| Cash from Financing | 22.47% | 38.71% | 45.84% | 8.63% | -19.72% |
| Foreign Exchange rate Adjustments | 301.80% | 2.37% | 1,600.81% | -131.13% | -2,590.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 187.18% | 340.71% | 9,174.97% | 6,836.91% | 825.69% |